These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 23708155)
1. A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study. Povsic TJ; Junge C; Nada A; Schatz RA; Harrington RA; Davidson CJ; Fortuin FD; Kereiakes DJ; Mendelsohn FO; Sherman W; Schaer GL; White CJ; Stewart D; Story K; Losordo DW; Henry TD Am Heart J; 2013 Jun; 165(6):854-861.e2. PubMed ID: 23708155 [TBL] [Abstract][Full Text] [Related]
2. The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina. Povsic TJ; Henry TD; Traverse JH; Fortuin FD; Schaer GL; Kereiakes DJ; Schatz RA; Zeiher AM; White CJ; Stewart DJ; Jolicoeur EM; Bass T; Henderson DA; Dignacco P; Gu Z; Al-Khalidi HR; Junge C; Nada A; Hunt AS; Losordo DW; JACC Cardiovasc Interv; 2016 Aug; 9(15):1576-85. PubMed ID: 27491607 [TBL] [Abstract][Full Text] [Related]
3. Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: an analysis from ACT34-CMI. Povsic TJ; Losordo DW; Story K; Junge CE; Schatz RA; Harrington RA; Henry TD Am Heart J; 2012 Nov; 164(5):689-697.e3. PubMed ID: 23137499 [TBL] [Abstract][Full Text] [Related]
4. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Losordo DW; Schatz RA; White CJ; Udelson JE; Veereshwarayya V; Durgin M; Poh KK; Weinstein R; Kearney M; Chaudhry M; Burg A; Eaton L; Heyd L; Thorne T; Shturman L; Hoffmeister P; Story K; Zak V; Dowling D; Traverse JH; Olson RE; Flanagan J; Sodano D; Murayama T; Kawamoto A; Kusano KF; Wollins J; Welt F; Shah P; Soukas P; Asahara T; Henry TD Circulation; 2007 Jun; 115(25):3165-72. PubMed ID: 17562958 [TBL] [Abstract][Full Text] [Related]
5. Intracoronary autologous CD34+ stem cell therapy for intractable angina. Wang S; Cui J; Peng W; Lu M Cardiology; 2010; 117(2):140-7. PubMed ID: 20975266 [TBL] [Abstract][Full Text] [Related]
6. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453 [TBL] [Abstract][Full Text] [Related]
7. Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease. Ripa RS Dan Med J; 2012 Mar; 59(3):B4411. PubMed ID: 22381094 [TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial. Kovacic JC; Macdonald P; Feneley MP; Muller DW; Freund J; Dodds A; Milliken S; Tao H; Itescu S; Moore J; Ma D; Graham RM Am Heart J; 2008 Nov; 156(5):954-63. PubMed ID: 19061712 [TBL] [Abstract][Full Text] [Related]
13. Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials. Henry TD; Losordo DW; Traverse JH; Schatz RA; Jolicoeur EM; Schaer GL; Clare R; Chiswell K; White CJ; Fortuin FD; Kereiakes DJ; Zeiher AM; Sherman W; Hunt AS; Povsic TJ Eur Heart J; 2018 Jun; 39(23):2208-2216. PubMed ID: 29315376 [TBL] [Abstract][Full Text] [Related]
15. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim. Weaver CH; Schulman KA; Buckner CD Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117 [TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493 [TBL] [Abstract][Full Text] [Related]
17. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621 [TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial). Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293 [TBL] [Abstract][Full Text] [Related]
19. Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris. Salem M; Rotevatn S; Stavnes S; Brekke M; Vollset SE; Nordrehaug JE Am J Cardiol; 2004 May; 93(9):1086-91. PubMed ID: 15110197 [TBL] [Abstract][Full Text] [Related]